Intractable Cancer
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Arsenic Trioxide for Structural p53 Mutations (NCT04695223) | Shanghai Changzheng Hospital | 2021-01-01 |
Track Intractable Cancer automatically
Every clearance here is in the API, with alerts when new ones post.